Community Bulletin
My Buckhannon's free weekly football pick 'em is back for 2026 with a rebuilt page, pick stats that go public once they lock and a leaderboard that crowns a season champion. Seven high school and college games a week, no entry fee and no password to sign in. Read more →
This story brought to you paywall-free, courtesy of the My Buckhannon team and our community partners
PHILIPPI, W.Va. –With the distribution of the COVID-19 vaccine underway in West Virginia and across the nation, Alderson Broaddus University continues efforts to advance the state’s vaccine rollout plan with the administration of the second dose of the COVID-19 vaccine to faculty and staff members on Thursday, January 28.
Alderson Broaddus began inoculating an initial group of 30 employees against COVID-19 with the mRNA-1273 vaccine, more commonly known as the Moderna vaccine, during the last week of December, and arrangements were underway to complete entrance testing ahead of the start of spring semester courses.
Undergraduate students were welcomed back to campus and face-to-face instruction on Wednesday, January 13. Upon arrival, all faculty, staff, and students were required to complete a saliva-based test to identify any positive cases before returning to in-classroom learning.
Of the nearly 900 members of the campus community who completed the entrance testing, less than three percent returned a positive result. All positive cases gleaned from the entrance testing completed their quarantine and isolation protocols.
“The safety and well-being of our entire campus community is our highest priority,” said Bruce Blankenship, COVID-19 response manager. “Individually and collectively, we have the personal and shared responsibility for keeping our community safe. Our commitment will enable all of us to enjoy a successful semester together.”
Testing efforts and a phased vaccination distribution are part of the plan developed by the West Virginia Joint Interagency Task Force in collaboration with the Higher Education Policy Commission. Employees over the age of 65 received priority, followed by those aged 50 and older and those in close contact with the public. Students in the health science field who work closely with patients in clinical settings have also been deemed a high priority.
All employees who requested to receive the vaccine will have been inoculated with their first dose by February 3, and vaccination efforts for eligible health science students have begun and will continue weekly.
Blankenship, alongside university officials, is reminding the campus community to remain vigilant. “At this time, we are still urging members of the AB community to continue to follow our existing guidelines and recommended health and safety measures.”
